View in EDS

A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results.

Saved in:
Bibliographic Details
Title: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results.
Authors: Palma, D.A.1,2, Kwan, K.3, Gaede, S.3, Landis, M.4, Malthaner, R.3, Fortin, D.3, Louie, A.V.2, Frechette, E.3, Rodrigues, G.2, Yaremko, B.5, Yu, E.1, Dar, A.R.5, Lee, T.Y.3, Gratton, A.1, Ward, A.D.6, Inculet, R.3
Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE473-E473. 1p.
Subjects: Cancer treatment, Non-small-cell lung carcinoma, Stereotactic radiotherapy, Cancer radiotherapy, Cancer tomography, Computed tomography, Positron emission tomography
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2016.06.1818